Physician profile
Manny Moy
NPI 1639162795
$1,787.33
in general payments reported to CMS, 2019-2025
20 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $251 · 2021: $211 · 2022: $467 · 2023: $218 · 2024: $47.75 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $508.27 | 2019-2024 | Collagenase Santyl |
| Organogenesis INC. | $382.79 | 2019-2022 | |
| Nevro Corp. | $146.98 | 2021-2023 | Senza |
| Stryker Corporation | $127.47 | 2020-2022 | |
| Djo, LLC | $112.36 | 2021-2025 | Cmf |
| Tactile Systems Technology INC | $68.40 | 2021-2022 | |
| Orthofix Medical, INC. | $46.42 | 2019-2023 | Physio-Stim |
| Wright Medical Technology, INC. | $45.76 | 2019-2020 | |
| Grt US Holding, INC. | $44.31 | 2022 | |
| Depuy Synthes Sales INC. | $43.12 | 2025 | Na |
| Arteriocyte Medical Systems, INC. | $38.21 | 2019-2023 | Magellan |
| Kci USA, INC. | $37.25 | 2020 | |
| Zimmer Biomet Holdings, INC. | $32.00 | 2020 | |
| Paragon 28, INC. | $31.62 | 2024 | Bun-Yo-Matic |
| Biocomposites INC | $26.82 | 2025 | Stimulan |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $22.71 | 2025 | Nuzyra |
| Medtronic, INC. | $20.53 | 2023 | Venaseal |
| Curonix LLC | $19.15 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Acera Surgical, INC. | $19.10 | 2022 | |
| Bioventus LLC | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manny Moy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.